September 22, 2017

September 22, 2017

Hearst CEO: Investing in Health
CNBC - Sept. 22"This effort by the fabulous Moffitt Cancer Center is an effort to put together the largest database of individual patients and their clinical data combined with the genetic data on the makeup of their individual cancer tumors," said Hearst President and CEO Steve Swartz.

ViewRay MRIdian to feature in 21 ASTRO presentations from seven leading centres
Medical Physics Web – Sept. 22
Recent customers that have been invited to the C2T2 include Dana-Farber/Brigham and Women's Cancer Center in Boston; Moffitt Cancer Center in Tampa, Florida; Institut du Cancer de Montpellier …

FLX Bio Selects Immuno-Oncology Clinical Candidate
Pharmiweb – Sept. 22
Dr. Antonia serves as the chair of the thoracic oncology department at the H. Lee Moffitt Cancer Center and Research Institute as well as professor of Oncologic Sciences at the University of South Florida College of Medicine. 

 “Clays For A Cure” A Charity Sporting Clays Tournament to Benefit Moffitt Cancer Center
Financial Executives – Sept. 22
Proceeds from this event will go to Bay Area Advisors to support Moffitt Cancer Center's vision to transform cancer care through service, science and partnership.

Breast Cancer Vaccine
KJCT – Sept. 21
Moffitt Cancer Center doctor Brian Czerniecki has been working on this vaccine for more than a decade.

How Ibrutinib Has Transformed the Treatment Paradigm of CLL
Targeted Oncology – Sept. 21
Javier Pinilla-Ibarz, MD, PhD, associate member, Malignant Hematology and Immunology Program at the H. Lee Moffitt Cancer Center, discusses how ibrutinib (Imbruvica) has transformed the treatment landscape of chronic lymphocytic leukemia (CLL).

Westchase community rallies for former Alonso catcher battling cancer
Tampa Bay Times – Sept. 21
Since the initial diagnosis, doctors at the Moffitt Cancer Center have administered two types of chemotherapy, while trying to shrink the tumorous mass across Abbott's chest, just beneath his rib cage.

BLU-554 Demonstrates Improved Response Rates in HCC
Targeted Oncology – Sept. 21
“Patients with hepatocellular carcinoma face a very poor prognosis with few therapeutic options,” said lead investigator Richard Kim, MD, associate professor, Moffitt Cancer Center.

CAR-T Cell TherapyRoundup
Clinical Oncology – Sept. 21
This trial, called ZUMA-3, was primarily a safety evaluation. The rates and types of adverse events (AEs) were considered acceptable overall. Other than the fatality, grade 3 or higher CRS only occurred in two patients (20%), and in both cases resolved, according to investigator Bijal D. Shah, MD, a hematologist/oncologist at Moffitt Cancer Center, in Tampa, Fla.

Improved Vaccine Protects Against 9 Cancer-Causing Strains of HPV
Contagion Live – Sept. 21
A study conducted by researchers from the Moffitt Cancer Center finds that the newest human papilloma virus (HPV) vaccine, 9vHPV, also known as Gardasil 9, is “highly effective” in the prevention of nine different strains of cervical cancer-causing HPV.

Managing negative emotions can help pregnant smokers quit
University of Buffalo – Sept. 21
The study results were published in the journal Nicotine & Tobacco Research. Co-authors include RIA researchers Paul R. Stasiewicz, Melanie Ruszczyk, Joseph F. Lucke, Rina D. Eiden, Kim S. Slosman and Paulette Giarratano; Yue Zhuo of the Sociology and Anthropology Department, St. John’s University; Stephen A. Maisto of the Department of Psychology; Syracuse University; and Thomas H. Brandon of the Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center.

M2Gen Harnesses both Clinical and Genetic Data to Accelerate New Treatments and Cures
PR Zoom – Sept. 21
Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States.

Physicians Develop Guidelines to Manage CAR T-Cell Toxicity
AJMC – Sept. 20
The review is based on the experiences gained when treating over 100 patients who received care at MD Anderson Cancer Center at the University of Texas, Moffitt Cancer Center in Tampa, Sylvester Cancer Center at the University of Miami, and Mayo Clinic Cancer Center in Rochester, Minneapolis.

Guidelines address ‘unmet need’ for grading, management of CAR T cell toxicities
Healio – Sept. 20
An expert panel of researchers — representing The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Sylvester Comprehensive Cancer Center and Mayo Clinic —developed a new grading system for neurotoxic events associated with chimeric antigen receptor T-cell therapies, according to guidelines published in Nature Reviews Clinical Oncology.

Proposed guidelines for handling CAR T cell side effects
European Pharmaceutical Review – Sept. 20
The review covers wide-ranging research on CAR T therapies by many institutions and includes insights based on more than 100 patients treated at MD Anderson, Moffitt Cancer Center in Tampa, Sylvester Cancer Center at the University of Miami, and Mayo Clinic Cancer Center in Rochester, Minn.

Moffitt CEO Alan List named to Beckers Hospital Reviews 112 Physician Leaders of Hospitals and Health Systems
Press Release Point – Sept. 20
The list features hospital and health system presidents and CEOs who also hold medical degrees.

M2Gen Raises Capital
Venture Capital News – Sept. 20
"Moffitt's culture is rooted in teamwork and collaboration. It is why we have been so successful at developing new treatments and bringing them to cancer patients," said Moffitt President and CEO Alan F. List, MD. 

M2Gen Harnesses both Clinical and Genetic Data to Accelerate New Treatments and Cures
Pharmacy Choice – Sept. 20
Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States. 

Hearst Invests $75M in M2Gen
GenomeWeb – Sept. 20
The money will support the expansion of the Oncology Research Information Exchange Network, which Moffitt, M2Gen, and Ohio State University created in 2014 to support data sharing among cancer centers, according to New York-based Hearst.

Hearst Invests in Moffitt Cancer Center Subsidiary M2Gen
Hearst.com – Sept. 20
Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States.

Hearst pumps $75M into Moffitt Cancer Center spinoff M2Gen
MedCityNews – Sept. 20
Moffitt Cancer Center‘s spinoff M2Gen, a healthcare informatics business that pairs big data analytics with cancer treatment, has received a $75 million investment from Hearst’s business media channel, according to the Tampa Bay Times. 

Hearst Invests In H. Lee Moffitt Cancer Center & Research Institute Subsidiary M2Gen
Biospace.com – Sept. 20
Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States. 

Hearst investment to aid cancer research
San Antonio Express News – Sept. 20
Hearst announced on Wednesday a $75 million equity investment in M2Gen, a health data and information subsidiary of Moffitt Cancer Center, to help accelerate the discovery of cancer therapies and improve care for patients nationwide.

Assessing and Managing CAR T-Cell Treatment Toxicities
ASCO Post - Sept. 20
The review covers wide-ranging research on CAR T therapies by many institutions, and includes insights based on more than 100 patients treated at MD Anderson, Moffitt Cancer Center, Sylvester Cancer Center at the University of Miami, and Mayo Clinic Cancer Center.

Bayside: Hungry Howie’s Love, Hope & Pizza (10/1 & 10/22)
CW44 – Sept. 20
To date, over 2 million dollars have been raised for breast cancer research and approximately. 20,000 free screenings have been provided benefiting women right here in the Bay area through a partnership with Moffitt Cancer Center.

Trigaux: How Moffitt Cancer's M2Gen startup won $75 million from Hearst
Tampa Bay Times – Sept. 20
A Moffitt Cancer Center spin-off that's building a massive genetic data base of individual patient cancer information just caught the attention of a deep-pocketed health care investor. Today, Hearst — a name once known for newspapers but who is now a powerful player in health care and technology — will announce a $75 million investment in the Moffitt spin-off known as M2Gen.

Hearst invests $75 million in Moffitt's M2Gen
Tampa Bay Business Journal – Sept. 20
M2Gen, a Moffitt Cancer Center subsidiary that uses big data to find ways to treat cancer, is receiving a $75 million equity investment from Hearst.

Hearst Invests in Moffitt Cancer Center Subsidiary M2Gen
Digital Journal – Sept. 20
Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States.

M2Gen Receives Equity Investment from Hearst
Finsmes – Sept. 20
M2Gen, a Tampa, FL-based health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States, received an equity investment from healthcare technology company Hearst.

Hearst invests in Moffitt Cancer Center subsidiary M2Gen
Pharmiweb – Sept. 20
Hearst, a market leader in healthcare technology, announced an equity investment in M2Gen, a health informatics subsidiary of Moffitt Cancer Center, one of the top comprehensive cancer centers in the United States. 

Hearst investment to aid cancer research
CT Post – Sept. 20
Hearst announced on Wednesday a $75 million equity investment in M2Gen, a health data and information subsidiary of Moffitt Cancer Center, to help accelerate the discovery of cancer therapies and improve care for patients nationwide.

Are You Prepared for Flu Season?
Cancer.net – Sept. 19
Stacy Martin, RN, BSN, CIC, is the manager of Infection Prevention & Control at Moffitt Cancer Center in Tampa, Florida. 

RNCG Angel Foundation Plans Costume Ball for “Scaring Off Cancer” Friday the 13th
Pittsburgh Post-Gazette – Sept. 19
A live and silent auction will delight attendees with fabulous items. Donations from the growing list of generous sponsors include Moffitt Cancer Center, The Dali Museum, Great Explorations Children's Museum, Tampa Theatre, Dolphin Landings Charter Boat Center, Total Restoration Services Group, Clearwater Marine Aquarium, StarLite Cruises, Birch and Vine, and Julie Weintraub's Hands Across the Bay to name a few. Also seen on AZCentral.com.

Researchers compose guidelines for handling CAR T cell side effects
Eurekalert – Sept. 19
The review covers wide-ranging research on CAR T therapies by many institutions and includes insights based on more than 100 patients treated at MD Anderson, Moffitt Cancer Center in Tampa, Sylvester Cancer Center at the University of Miami, and Mayo Clinic Cancer Center in Rochester, Minn. Also seen at MedIndia.net, eCancer.org and Managed Care Magazine.

Tampa-based Artificially Intelligent Cyber Defense Firm Welcomes New Advisory Board Member
PR Web – Sept. 19
Sharpe is a 20-year Navy Intelligence Veteran who was elected to the Hillsborough County Commission in 2004, where he served 10 years before terming out in 2014. As chief potential officer of !P, he has successfully grown the organization’s membership beyond four initial anchor institutions (University of South Florida, Florida Hospital, Busch Gardens and Moffitt Cancer Center) to include over 250 businesses and community members. Also seen on KSLA.

Kymriah approval generates questions about cost, access, long-term impact of CAR T-cell therapy
Healio – Sept. 18
HemOnc Today spoke with Brown and Bijal D. Shah, MD, a medical oncologist in the malignant oncology program at Moffitt Cancer Center, about the approval of tisagenlecleucel, the potential for a practice-changing shift in the treatment of refractory B-cell precursor ALL and the barriers that may affect access to this therapy, as well as strategies for addressing these concerns. 

Pale is the new tan, dermatologist tells patients
The Hamilton Spectator – Sept. 18
Tourists and residents in Florida can avoid the possible fatal outcomes from skin cancer with a game plan, said Dr. Nikhil Khushalani, one of the top cancer doctors at Tampa's Moffitt Cancer Center, which is the National Cancer Institute's only designated Comprehensive Cancer Center in Florida. Also seen at The Journal Times.

Triple-Negative Breast Cancer Treatment Market Projected to Gain Significant Value by 2025
MilTech – Sept. 18
According to the research article published in Journal of the Moffitt Cancer Center, around 1 million breast cancers are diagnosed globally among them 1.7% of cancer cases are triple-negative cancers. 

BLU-554 Associated With Improved Response in HCC
OncLive – Sept. 17
“Patients with hepatocellular carcinoma face a very poor prognosis with few therapeutic options,” said lead investigator Richard Kim, MD, associate professor, Moffitt Cancer Center. 

National Organization on Disability Announces Winners of 2017 Leading Disability Employer Seal
Insurance News – Sept. 17
The 2017 NOD Leading Disability Employer Seal winners are: … Moffitt Cancer Center

Vin’s People
Saraosta Herald Tribune – Sept. 16
The indomitable Patty Virgilio was honored Saturday at the Trop during Moffitt’s Salute to Survivors, which recognizes their patients for courage during their cancer journey. The B’town resident, who has beaten thyroid cancer and breast cancer, has been battling pancreatic cancer.

Harmonic Drive describe surgical robots and their potential
Gears of Biz – Sept. 16
There are three main types of surgical robot: autonomous, dependent and shared-control. Writing in Cancer Control, journal of the Moffitt Cancer Center, the authors Doulgeris, Gonzales-Blohm and Filis et al, explain that “autonomous systems reproduce programmed motions … dependent systems [are where]the surgeon maintains full control of the system at all times … [and]shared-control systems are a hybrid.

New study finds improved vaccine that protects against nine types of HPV
Gears of Biz – Sept. 15
The researchers, including those from Moffitt Cancer Center, published the final results of a study showing the newest vaccine is highly effective at preventing HPV infection and disease. The study was published this week in The Lancet.

Hurricane Irma will have lasting impact on hospital finances, Moody's says
Healthcare Finance – Sept. 15
More than 20 Moody's-rated health systems closed various outpatient services or physician offices due to Irma's ferocity. Relatively few hospitals actually closed, at this point most outpatient services have resumed. Among the institutions with the most impacted services … H. Lee Moffitt Cancer Center; Shands Jacksonville Medical Center; and Adventist Health System Sunbelt.

Best Doctors in Tampa Bay
Tampa Bay Metro – Sept. 15
For 16 years, Tampa Bay METRO has partnered with Best Doctors, Inc. to provide a valuable community resource. The list includes the Bay area’s most respected specialists and outstanding primary care physicians in the nation. 

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.